Roger Bate

Featured

https://www.reutersconnect.com/all?id=tag%3Areuters.com%2C2020%3Anewsml_RC27XG9M9BN0&share=true

Demand for Hydroxychloroquine Has Revealed Some Clear Quality Issues

Top Stories

The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed by a pharmacist at the Rock Canyon Pharmacy in Provo, Utah, U.S

Did British Scientists Jump the Gun On Hydroxychloroquine?

U.S. Customs and Border Protection officer Boris Sapozhnikov looks at counterfeit drugs seized by the agency at its offices at John F. Kennedy Airport in New York August 15, 2012. REUTERS/Keith Bedford

Coronavirus Lockdowns Are Allowing Chloroquine Counterfeiters To Run Rampant

Congress Takes Action To Reduce U.S. Reliance On Chinese Drugs

China Must Accept Responsibility For Making COVID-19 Coronavirus Worse

Reuters

Will Health Leaders Rewrite History Over the Coronavirus?

View All Top Stories

Roger Bate's Stories

A discarded syringe is seen under a bridge on Lester Avenue in Johnson City, New York, U.S., April 7, 2018. Picture taken April 7, 2018. REUTERS/Andrew Kelly

There's Something Missing from Trump's China Deal: Opioids

British Media Is Biased On Discussions Of Climate Change

Reuters

Superbugs Are Here to Stay

We Can't Overlook Adults In The Vaping Health Epidemic

The Vaping Craze Is Driving America's Newest Black Market

Can America Regulate Itself Out Of The Vaping Crisis?

Reuters

China Must Stop Exporting Illicit Vaping Cartridges to America